• Health & Medicine
• Science & Technology

News digest – Testosterone, artificial intelligence, genetic tests, the HPV vaccine and… a cuppa?

Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier. Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier.

11 November 2017

• Health & Medicine

The HPV vaccine and cervical screening: how many tests do you need?

New research shows women who have had the HPV vaccine may only need 3 cervical screens in their entire life, rather than the 12 that are standard in the UK. New research shows women who have had the HPV vaccine may only need 3 cervical screens in their entire life, rather than the 12 that are standard in the UK.

10 November 2017

• Health & Medicine

NHS data shows drop in cervical cancer screening attendance

Less than three quarters of eligible women are attending cervical cancer screening appointments in England, according to new figures. Less than three quarters of eligible women are attending cervical cancer screening appointments in England, according to new figures.

10 November 2017

• Health & Medicine

HPV jab means women only need three cervical screens in a lifetime

Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine. Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine.

10 November 2017

• Science & Technology

NCRI 2017: How knowing tumours inside and out is boosting progress

In our round-up of this year's NCRI conference we reveal exciting new research that's helping scientists get to know cancer better. In our round-up of this year's NCRI conference we reveal exciting new research that's helping scientists get to know cancer better.

8 November 2017

• Health & Medicine

Risk of certain breast cancers coming back remains for at least 20 years after treatment

New research says the risk of a certain type of breast cancer coming back in other parts of the body stays constant for at least 20 years after treatment. New research says the risk of a certain type of breast cancer coming back in other parts of the body stays constant for at least 20 years after treatment.

8 November 2017

• Health & Medicine

Big data analysis predicts risk of radiotherapy side effects

Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer. Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer.

7 November 2017

• For Researchers

Celebrating a lifetime in cancer prevention, translating evolutionary biology, and our leaders of tomorrow: the 2017 CRUK Research Prizes

Our 2017 Research Prizes celebrate the achievements of rising stars in cancer research, and researchers who have shown outstanding dedication to beating cancer. Our 2017 Research Prizes celebrate the achievements of rising stars in cancer research, and researchers who have shown outstanding dedication to beating cancer.

6 November 2017

• Health & Medicine

Test could diagnose oesophageal cancer 8 years earlier

A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease. A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease.

6 November 2017

• Health & Medicine

Test could diagnose oesophageal cancer 8 years earlier

A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease. A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease.

6 November 2017

• Health & Medicine
• Science & Technology

Scientists exploit leaks in blood brain barrier to treat glioblastoma

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma. An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma.

6 November 2017

• Health & Medicine
• Science & Technology

News digest – gut bacteria, aspirin, bowel cancer in women and… ‘wonky willy’ cancer risk?

Our top stories this week: gut bacteria may influence immunotherapy, emergency bowel cancer diagnoses in women and lunch ‘meal deals’ are too sugary. Our top stories this week: gut bacteria may influence immunotherapy, emergency bowel cancer diagnoses in women and lunch ‘meal deals’ are too sugary.

4 November 2017